openPR Logo
Press release

Gastric Inhibitory Polypeptide Receptor Market Key Players – Longevity Biotech Inc, Novo Nordisk AS, and Sanofi Analysis and Forecast to 2022

02-20-2018 10:16 AM CET | Health & Medicine

Press release from: WiseGuy Research consultants Pvt Ltd.

/ PR Agency: WISEGUY RESEARCH CONSULTANTS PVT LTD
Gastric Inhibitory Polypeptide Receptor

Gastric Inhibitory Polypeptide Receptor

Gastric Inhibitory Polypeptide Receptor

Overview

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 12 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes.

The latest report Gastric Inhibitory Polypeptide Receptor - Pipeline Review, H1 2018, outlays comprehensive information on the Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811473-gastric-inhibitory-polypeptide-receptor-glucose-dependent-insulinotropic-polypeptide-receptor-or

Top Companies mentioned

Antag Therapeutics ApS

Carmot Therapeutics Inc

Eli Lilly and Co

Hanmi Pharmaceuticals Co Ltd

Longevity Biotech Inc

Novo Nordisk AS

Sanofi

Zealand Pharma AS

Antag Therapeutics ApS

Gastric Inhibitory Polypeptide Receptor Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Gastric Inhibitory Polypeptide Receptor  - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Gastric Inhibitory Polypeptide Receptor , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Glucose-dependent insulinotropic polypeptide is released from the duodenum and small intestine. GIP binds to GIPR though hydrophobic interactions and triggering activation of G protein-coupled receptors, which in turn causes an enzymatic cascade resulting in the increased secretion of insulin. Endogeonous ligands for the receptor include oleylethanolamide and lysophosphatidylcholine. The cause of type 2 diabetes is due to the inability of GIP to bind properly to GIPR. The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 5 and 1 respectively. 

Gastric Inhibitory Polypeptide Receptor pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Gastric Inhibitory Polypeptide Receptor - Competitive Analysis

Key players are making innovative developments in Gastric Inhibitory Polypeptide Receptor industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Gastric Inhibitory Polypeptide Receptor.

The pipeline guide reviews pipeline therapeutics for Gastric Inhibitory Polypeptide Receptor by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Gastric Inhibitory Polypeptide Receptor therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Gastric Inhibitory Polypeptide Receptor therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Gastric Inhibitory Polypeptide Receptor.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2811473-gastric-inhibitory-polypeptide-receptor-glucose-dependent-insulinotropic-polypeptide-receptor-or

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastric Inhibitory Polypeptide Receptor Market Key Players – Longevity Biotech Inc, Novo Nordisk AS, and Sanofi Analysis and Forecast to 2022 here

News-ID: 949640 • Views:

More Releases from WiseGuy Research consultants Pvt Ltd.

Beauty Drinks Market and its Future Outlook and Trend During the Period of 2019 – 2025
Beauty Drinks Market and its Future Outlook and Trend During the Period of 2019 …
Global Beauty Drinks Market Research Report 2019 Summary: - Wiseguyreports.Com Adds “Beauty Drinks - Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2025” To Its Research Database. Overview: Beauty drinks refer to both carbonated and non-carbonated beverages, which is used to retain natural beauty during aging. The beauty drinks contain various vitamins, minerals, amino acids, and antioxidants. It aids to support diets by encouraging metabolism. The global beauty drinks market
Global Capsule Endoscopy Treatment Solutions Market 2020: key Vendors, Trends, A …
Summary A New Market Study, titled “Capsule Endoscopy Treatment Solutions Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports. This report provides in depth study of “Capsule Endoscopy Treatment Solutions Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Capsule Endoscopy Treatment Solutions Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such
Data Center Colocation Market 2019: Size, Share, Demand, Trends, Growth and 2025 …
Global Data Center Colocation Industry New Study On “2019-2025 Data Center Colocation Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database Data center operators face an increasing need for scalable data center infrastructure, which enables the scaling of critical data center components as and when the demand increases. The data center colocation provides data center space, along with the power and cooling infrastructure, which address
Temperature Logger Market 2019 Trends, Research, Analysis & Review Forecast 2025
Global Temperature Logger Industry New Study On “2019-2025 Temperature Logger Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database This report studies the global Temperature Logger market status and forecast, categorizes the global Temperature Logger market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The

All 5 Releases


More Releases for Polypeptide

Specific Polypeptide Analyzers Research:CAGR of 4.2% during the forecast period
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2024 latest report "Automatic Specific Polypeptide Analyzer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030". Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few
Synthesis Polypeptide Drugs Market Research Insights with Opportunities, Segmen …
Worldwide Market Reports introducing highly anticipated "Synthesis Polypeptide Drugs Market" research report, 'The Future of Industries: Unveiling Key Market Insights and Growth Opportunities.' This comprehensive and insightful Synthesis Polypeptide Drugs report is a game-changer for businesses seeking to thrive in today's dynamic market landscape. With an extensive scope covering multiple industries, our report offers a detailed analysis of current market trends, consumer behavior, competitive landscapes, and emerging opportunities. Harnessing the power
Islet Amyloid Polypeptide: Therapeutic Developments to Witness Growth
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Islet amyloid polypeptide (IAPP) or Amylin is a peptide hormone. This hormone is released from pancreatic beta cells following food intake to regulate blood glucose levels and act as a satiation signal. It inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. The molecules developed by companies in Phase II, Phase I and Preclinical stages
Islet Amyloid Polypeptide: Therapeutic Developments to Witness Growth
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Islet amyloid polypeptide (IAPP) or Amylin is a peptide hormone. This hormone is released from pancreatic beta cells following food intake to regulate blood glucose levels and act as a satiation signal. It inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. The molecules developed by companies in Phase II, Phase I and Preclinical stages
Polypeptide Market Discern Magnified Growth By 2028
With an increasing number of patients diagnosed with cancer, many pharmaceutical companies are conducting intensive research to discover effective anti-cancer drugs. The World Health Organization (WHO), cancer was the second leading cause of death, killing over 8.8 million people across the globe. 70% patients in low- or middle-income countries, who are diagnosed with cancer succumb to death. It generates needs for an effective oncology medicine that can reduce the number
Polypeptide Market Analysis , Trends, Opportunity, 2018 to 2028
Global Polypeptides Market: Overview Polypeptides, the organic polymers containing a large number of amino-acids bonded together on the form of a chain, represent essential portions of proteins with unique pharmacokinetic properties as compared to small molecule drugs and large proteins. Polypeptides play a crucial role in modulating cellular functions and coordinating intercellular communications. There are hardly any other classes of bio-molecules that offer as much chemical diversity as polypeptides do. Researchers have